March 2026 - Cardiac Care

Supporting
Contemporary Cardiac Care

Focus on high-sensitivity troponin testing

By Dr David Deam
Published March 2026

Australian Clinical Labs will shortly withdraw CK-MB from its routine test repertoire. Contemporary practice now relies on cardiac troponin I or T as the recommended laboratory markers for myocardial infarction, reflecting their superior sensitivity and specificity.

Hospital admission and management decisions should not be delayed while awaiting laboratory results. Testing complements clinical assessment and ECG findings, particularly when ECG changes are non-specific or left bundle branch block is present.

High-sensitivity troponin assays typically become abnormal within 1–3 hours of symptom onset and may remain elevated for 7–10 days. Serial testing is recommended to demonstrate a rise or fall in concentration, with myocardial infarction defined by dynamic troponin change and at least one value above the 99th percentile in the appropriate clinical context.

GPs should continue to request high-sensitivity troponin for suspected acute coronary syndromes and contact the laboratory for advice in unusual cases or when CK-MB is being requested.